Sitravatinib Uses, Dosage, Side Effects and more
Sitravatinib is under investigation in clinical trial NCT03680521 (Neoadjuvant Sitravatinib in Combination With Nivolumab in Patients With Clear Cell Renal Cell Carcinoma).
| Attribute | Details |
|---|---|
| Trade Name | Sitravatinib |
| Generic | Sitravatinib |
| Sitravatinib Other Names | Sitravatinib |
| Type | |
| Formula | C33H29F2N5O4S |
| Weight | Average: 629.68 Monoisotopic: 629.190831934 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
